Editorial Standards
How Peptide Basics selects topics, uses primary sources, describes study evidence and regulatory status, and handles corrections and updates.
Topic selection
We cover topics relevant to peptide science and its real-world context: new research, clinical trial results, regulatory actions, analytical quality, drug development and notable industry events. A topic is chosen because it is relevant to readers trying to understand peptides, not because a company or individual requests coverage.
Primary sources
Articles should rely on primary sources wherever they exist: the peer-reviewed paper, the trial registry entry, the regulatory document, the official transcript or show notes. Secondary reporting may provide context but is not treated as a substitute for the original.
Describing studies
When an article discusses a study, it should link to an identifiable source such as a journal article, PubMed record or registry entry, and describe the study design, the species or population studied, the sample size, and relevant limitations. Findings from a single small study are not presented as settled.
Regulatory coverage
Coverage of FDA actions should be based on primary FDA documents, including approval letters, labeling, guidance documents, warning letters and advisory committee materials. Articles explain what a specific action does and does not mean, and avoid broadening a narrow decision into a general claim.
Preclinical, clinical and approved use
We distinguish clearly between preclinical evidence (cell and animal studies), clinical evidence (studies in people, by phase), and approved use (indications authorized by a regulator). Biological activity in a lab model is not described as proven clinical benefit, and investigational products are identified as investigational.
Company and source releases
Press releases, company statements, supplier documentation and claims made by interview guests are reported as claims. They are not treated as independent validation of efficacy, safety or quality.
Editorial independence
Brian Gossett, the author of Peptide Basics articles, is also the founder of Base Peptides, a research peptide supplier. This commercial relationship is disclosed in article author blocks and on his author profile.
Editorial judgments about what to cover and how to describe evidence should not be determined by commercial interests. Where a page contains commercial relationships, such as links to providers or suppliers, those relationships should not change how evidence is presented.
Use of Artificial Intelligence
Peptide Basics uses artificial intelligence tools to assist with research organization, source discovery, drafting, and editing. Published articles are directed, reviewed, and edited by the identified author. AI-generated material is not treated as a primary source; scientific and regulatory claims should be supported by cited underlying sources.
Corrections and updates
If you believe an article contains an error, please tell us through the contact page. When an article is materially revised, its updated date is changed to reflect the revision.
Not medical advice
All content is educational. It is not medical advice, diagnosis or treatment, and it does not replace consultation with a qualified, licensed medical professional.